Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1995 Sep;86(1):79–84.

Establishment of T-helper type 1- and T-helper type 2-like human Toxoplasma antigen-specific T-cell clones.

W Däubener 1, C Mackenzie 1, U Hadding 1
PMCID: PMC1383813  PMID: 7590886

Abstract

As an in vitro model for human cerebral toxoplasmosis, we analysed the interaction between glioblastoma cells, Toxoplasma and Toxoplasma antigen-specific T-helper cells. We established 46 different human CD4+ T-cell clones from four different donors. All T-cell clones responded to Toxoplasma antigen derived from three different Toxoplasma strains. We found that the supernatants of 44 clones induced toxoplasmostasis in glioblastoma cells. The anti-parasitic effector mechanism activated in glioblastoma cells by T-cell supernatants was the induction of the tryptophan-degrading enzyme indolamine 2,3-dioxygenase. Enzyme induction, as well as the anti-parasitic effect, was blocked by a monoclonal antibody directed against interferon-gamma (IFN-gamma), and the addition of L-tryptophan to the cultures completely blocked the anti-parasitic effect induced by T-cell supernatants. The supernatants from two of the 46 established T-cell clones (3A22 and 1A15) were unable to induce indolamine 2,3-dioxygenase activity or, as expected, toxoplasmostasis in glioblastoma cells. We further analysed the supernatants from these two clones, and found that they contained large amounts of IL-4 and no, or only limited amounts of, IFN-gamma. We therefore conclude that Toxoplasma-antigen is able to activate T-helper type 1 (Th1)- and Th2-like human T cells, and only IFN-gamma-producing cells are capable of inducing anti-parasitic effector mechanisms.

Full text

PDF
79

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adams L. B., Hibbs J. B., Jr, Taintor R. R., Krahenbuhl J. L. Microbiostatic effect of murine-activated macrophages for Toxoplasma gondii. Role for synthesis of inorganic nitrogen oxides from L-arginine. J Immunol. 1990 Apr 1;144(7):2725–2729. [PubMed] [Google Scholar]
  2. Anderson S. E., Bautista S., Remington J. S. Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products. J Immunol. 1976 Aug;117(2):381–387. [PubMed] [Google Scholar]
  3. Araujo F. G. Depletion of CD4+ T cells but not inhibition of the protective activity of IFN-gamma prevents cure of toxoplasmosis mediated by drug therapy in mice. J Immunol. 1992 Nov 1;149(9):3003–3007. [PubMed] [Google Scholar]
  4. Bilzer T., Stavrou D., Dahme E., Keiditsch E., Bürrig K. F., Anzil A. P., Wechsler W. Morphological, immunocytochemical and growth characteristics of three human glioblastomas established in vitro. Virchows Arch A Pathol Anat Histopathol. 1991;418(4):281–293. doi: 10.1007/BF01600156. [DOI] [PubMed] [Google Scholar]
  5. Canessa A., Pistoia V., Roncella S., Merli A., Melioli G., Terragna A., Ferrarini M. An in vitro model for Toxoplasma infection in man. Interaction between CD4+ monoclonal T cells and macrophages results in killing of trophozoites. J Immunol. 1988 May 15;140(10):3580–3588. [PubMed] [Google Scholar]
  6. Däubener W., Pilz K., Seghrouchni Zennati S., Bilzer T., Fischer H. G., Hadding U. Induction of toxoplasmostasis in a human glioblastoma by interferon gamma. J Neuroimmunol. 1993 Mar;43(1-2):31–38. doi: 10.1016/0165-5728(93)90072-7. [DOI] [PubMed] [Google Scholar]
  7. Däubener W., Wanagat N., Pilz K., Seghrouchni S., Fischer H. G., Hadding U. A new, simple, bioassay for human IFN-gamma. J Immunol Methods. 1994 Jan 12;168(1):39–47. doi: 10.1016/0022-1759(94)90207-0. [DOI] [PubMed] [Google Scholar]
  8. Däubener W., Zennati S. S., Wernet P., Bilzer T., Fischer H. G., Hadding U. Human glioblastoma cell line 86HG39 activates T cells in an antigen specific major histocompatibility complex class II-dependent manner. J Neuroimmunol. 1992 Nov;41(1):21–28. doi: 10.1016/0165-5728(92)90191-m. [DOI] [PubMed] [Google Scholar]
  9. Fontana A., Frei K., Bodmer S., Hofer E. Immune-mediated encephalitis: on the role of antigen-presenting cells in brain tissue. Immunol Rev. 1987 Dec;100:185–201. doi: 10.1111/j.1600-065X.1987.tb00532.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Khan I. A., Eckel M. E., Pfefferkorn E. R., Kasper L. H. Production of gamma interferon by cultured human lymphocytes stimulated with a purified membrane protein (P30) from Toxoplasma gondii. J Infect Dis. 1988 May;157(5):979–984. doi: 10.1093/infdis/157.5.979. [DOI] [PubMed] [Google Scholar]
  11. Khan I. A., Smith K. A., Kasper L. H. Induction of antigen-specific human cytotoxic T cells by Toxoplasma gondii. J Clin Invest. 1990 Jun;85(6):1879–1886. doi: 10.1172/JCI114649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Khan I. A., Smith K. A., Kasper L. H. Induction of antigen-specific parasiticidal cytotoxic T cell splenocytes by a major membrane protein (P30) of Toxoplasma gondii. J Immunol. 1988 Nov 15;141(10):3600–3605. [PubMed] [Google Scholar]
  13. Murray H. W., Rubin B. Y., Carriero S. M., Harris A. M., Jaffee E. A. Human mononuclear phagocyte antiprotozoal mechanisms: oxygen-dependent vs oxygen-independent activity against intracellular Toxoplasma gondii. J Immunol. 1985 Mar;134(3):1982–1988. [PubMed] [Google Scholar]
  14. Murray H. W., Szuro-Sudol A., Wellner D., Oca M. J., Granger A. M., Libby D. M., Rothermel C. D., Rubin B. Y. Role of tryptophan degradation in respiratory burst-independent antimicrobial activity of gamma interferon-stimulated human macrophages. Infect Immun. 1989 Mar;57(3):845–849. doi: 10.1128/iai.57.3.845-849.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Murray H. W., Teitelbaum R. F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J Infect Dis. 1992 Mar;165(3):513–517. doi: 10.1093/infdis/165.3.513. [DOI] [PubMed] [Google Scholar]
  16. Murray H. W., Teitelbaum R., Hariprashad J. Response to treatment for an intracellular infection in a T cell-deficient host: toxoplasmosis in nude mice. J Infect Dis. 1993 May;167(5):1173–1177. doi: 10.1093/infdis/167.5.1173. [DOI] [PubMed] [Google Scholar]
  17. Nibbering P. H., Langermans J. A., van de Gevel J. S., van der Hulst M. B., van Furth R. Nitrite production by activated murine macrophages correlates with their toxoplasmastatic activity, Ia antigen expression, and production of H2O2. Immunobiology. 1991 Dec;184(1):93–105. doi: 10.1016/S0171-2985(11)80575-9. [DOI] [PubMed] [Google Scholar]
  18. Pfefferkorn E. R. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A. 1984 Feb;81(3):908–912. doi: 10.1073/pnas.81.3.908. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Saavedra R., Hérion P. Human T-cell clones against Toxoplasma gondii: production of interferon-gamma, interleukin-2, and strain cross-reactivity. Parasitol Res. 1991;77(5):379–385. doi: 10.1007/BF00931632. [DOI] [PubMed] [Google Scholar]
  20. Saavedra R., de Meuter F., Decourt J. L., Hérion P. Human T cell clone identifies a potentially protective 54-kDa protein antigen of Toxoplasma gondii cloned and expressed in Escherichia coli. J Immunol. 1991 Sep 15;147(6):1975–1982. [PubMed] [Google Scholar]
  21. Sibley L. D., Boothroyd J. C. Virulent strains of Toxoplasma gondii comprise a single clonal lineage. Nature. 1992 Sep 3;359(6390):82–85. doi: 10.1038/359082a0. [DOI] [PubMed] [Google Scholar]
  22. Subauste C. S., Remington J. S. Immunity to Toxoplasma gondii. Curr Opin Immunol. 1993 Aug;5(4):532–537. doi: 10.1016/0952-7915(93)90034-p. [DOI] [PubMed] [Google Scholar]
  23. Suzuki Y., Orellana M. A., Schreiber R. D., Remington J. S. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science. 1988 Apr 22;240(4851):516–518. doi: 10.1126/science.3128869. [DOI] [PubMed] [Google Scholar]
  24. Suzuki Y., Remington J. S. Dual regulation of resistance against Toxoplasma gondii infection by Lyt-2+ and Lyt-1+, L3T4+ T cells in mice. J Immunol. 1988 Jun 1;140(11):3943–3946. [PubMed] [Google Scholar]
  25. Suzuki Y., Remington J. S. Toxoplasmic encephalitis in AIDS patients and experimental models for study of the disease and its treatment. Res Immunol. 1993 Jan;144(1):66–67. doi: 10.1016/s0923-2494(05)80102-6. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES